Category: Ecosystem News

Vivaldi Biosciences Files PCT Patent Application for Universal Flu and Covid-19 Combination Vaccine

By: Colorado BioScience Association   Date: 11/30/2021

Vivaldi Biosciences, a clinical-stage biotechnology company developing nasal-spray vaccines for viral respiratory diseases, today announced it has filed an international patent application for its com...

Learn More

SolidAIRity Flex™ Launches First-in-Patient Limited Market Release

By: Colorado BioScience Association   Date: 11/22/2021

Securisyn Medical has formally launched its FDA-registered, Adult SolidAIRity Flex™ Endotracheal Tube Securement device, at Memorial Hospital - University of Colorado Health in Colorado Springs. This...

Learn More

Aspero Medical Awarded $1M Grant

By: Colorado BioScience Association   Date: 11/09/2021

Startup MedTech company improving endoscopy procedures with patented balloon technology continues to develop product line Aspero Medical, a medical device startup company focused on design and develop...

Learn More

CBSA Member SmartTab Receives Two Awards: 2021 Colorado Company to Watch and 2021 Patient's Choice Award

By: Colorado BioScience Association   Date: 10/22/2021

CBSA member SmartTab is honored with two awards: SmartTab has been selected as a top award winner for the 2021 Colorado Companies to Watch. This highly prestigious award is designated to the most, “in...

Learn More

PharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign

By: Colorado BioScience Association   Date: 10/21/2021

 PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia d...

Learn More

PharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress - Europe

By: Colorado BioScience Association   Date: 10/13/2021

Superior immunogenicity expands vaccine development with Needle-free delivery PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and resear...

Learn More

Weekly Policy Update: Prescription Drug Affordability Review Board Members Appointed

By: Colorado BioScience Association   Date: 10/08/2021

This week, Governor Polis announced the appointment of the inaugural five members of the Prescription Drug Affordability Review Board (PDAB). The PDAB was created through the legislature’s passage and...

Learn More

Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta

By: Colorado BioScience Association   Date: 10/07/2021

The Gates Biomanufacturing Facility (GBF) today announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this col...

Learn More

Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients

By: Colorado BioScience Association   Date: 10/07/2021

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for...

Learn More

New fund expands its investments into the Mid-America Mountain Plains region focusing on B2B SaaS, Cleantech, and Medtech Startups

By: Colorado BioScience Association   Date: 10/05/2021

Innosphere Ventures announced the launch of its second venture capital fund, Innosphere Ventures Fund II (Fund II), that focuses on leading early-stage investments for companies who are driving innova...

Learn More